CD68 and neoplasm: Tumours with high IL-34 plus high CD68+-TAMs had the best prognosis, tumours with high or low IL-34 plus low or high CD68+-TAMs had mid-level prognosis and tumours with low IL-34 plus low CD68+-TAMs had the worst prognosis in GC patients.